Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers
Clinical trial NCT02734615 · TERMINATED
Trial details
- NCT number
- NCT02734615
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-14
- Primary completion
- 2021-09-13
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.